<H1>Chapter DOI: 10.1208/aapsj070362<br/>Cited-By Count: 15</H1><table border="1" width="30%"><tr><td>Total References</td><td>74</td></tr><tr><td>Springer references</td><td>7</td></tr><tr><td>Non Springer references</td><td>67</td></tr><tr><td>BibStructured Count</td><td width="10%">72</td></tr><tr><td>BibUnstructured Count</td><td width="10%">2</td></tr><tr><td>DOI already available in SpringerLink</td><td>45</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>11</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>1</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>2</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>1</td></tr><tr><td>DOI Obtained For Non Springer</td><td>11</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>12</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>10</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Muller M. Microdialysis in clinical drug delivery studies.<Emphasis Type="Italic">Adv Drug Deliv Rev.</Emphasis> 2000;45:255&#8211;269.</td><td><a href=http://dx.doi.org/10.1016/S0169-409X(00)00113-7>10.1016/S0169-409X(00)00113-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>de la Pena A, Liu P, Derendorf H. Microdialysis in peripheral tissues.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2000;45:189&#8211;216.</td><td><a href=http://dx.doi.org/10.1016/S0169-409X(00)00106-X>10.1016/S0169-409X(00)00106-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Ungerstedt U. Microdialysis&#8212;principles and applications for studies in animals and man.<Emphasis Type="Italic">J Intern Med.</Emphasis> 1991;230:365&#8211;373.</td><td><a href=http://dx.doi.org/10.1111/j.1365-2796.1991.tb00459.x>10.1111/j.1365-2796.1991.tb00459.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Muller M, Haag O, Burgdorff T, et al. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans.<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 1996;40:2703&#8211;2709.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Joukhadar, C, Derendorf H, Muller M. Microdialysis. A novel tool for clinical studies of anti-infective agents.<Emphasis Type="Italic">Eur J Clin Pharmacol.</Emphasis> 2001;57:211&#8211;219.</td><td><a href=http://dx.doi.org/10.1007/s002280100301>10.1007/s002280100301</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Chalmers GW, Thomson L, Macleod KJ, et al. Endothelin-1 levels in induced sputum samples from asthmatic and normal subjects.<Emphasis Type="Italic">Thorax</Emphasis>. 1997;52:625&#8211;627.</td><td><a href=http://dx.doi.org/10.1136/thx.52.7.625>10.1136/thx.52.7.625</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Conte JEJr, Golden JA, Kipps J, McIver M, Zurlinden E. Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 2004;48:3823&#8211;3827.</td><td><a href=http://dx.doi.org/10.1128/AAC.48.10.3823-3827.2004>10.1128/AAC.48.10.3823-3827.2004</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Ingvast-Larsson C, Appelgren LE, Nyman G. Distribution studies of theophylline: microdialysis in rat and horse and whole body autoradiography in rat.<Emphasis Type="Italic">J Vet Pharmacol Ther</Emphasis>. 1992;15:386&#8211;394.</td><td><a href=http://dx.doi.org/10.1111/j.1365-2885.1992.tb01030.x>10.1111/j.1365-2885.1992.tb01030.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Tomaselli F, Dittrich P, Maier A, et al. Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.<Emphasis Type="Italic">Br J Clin Pharmacol</Emphasis>. 2003;55:620&#8211;624.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2125.2003.01797.x>10.1046/j.1365-2125.2003.01797.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Herkner H, Muller MR, Kreischitz N, et al. Closed-chest microdialysis to measure antibiotic penetration into human lung tissue.<Emphasis Type="Italic">Am J Respir Crit Care Med.</Emphasis> 2002;165:273&#8211;276.</td><td><a href=http://dx.doi.org/10.1164/ajrccm.165.2.2106082>10.1164/ajrccm.165.2.2106082</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, VolumeID, Author_FamilyName_1, Year, JournalTitle</td><td>CrossRef</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Tomaselli F, Maier A, Matzi V, Smolle-Juttner FM, Dittrich P. Penetration of meropenem into pneum onic humanlung tissue as measured by in vivo microdialysis.<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 2004;48:2228&#8211;2232.</td><td><a href=http://dx.doi.org/10.1128/AAC.48.6.2228-2232.2004>10.1128/AAC.48.6.2228-2232.2004</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Liu P, Muller M, Grant M, Webb AI, Obermann B, Derendorf H. Interstitial tissue concentrations of cefpodoxime.<Emphasis Type="Italic">J Antimicrob Chemother.</Emphasis> 2002;50:19&#8211;22.</td><td><a href=http://dx.doi.org/10.1093/jac/dkf058>10.1093/jac/dkf058</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Grubb BR, Jones JH, Boucher RC Mucociliary transport determined by in vivo microdialysis in the airways of normal and CF mice.<Emphasis Type="Italic">Am J Physiol Lung Cell Mol Physiol.</Emphasis> 2004; 286:L588-L595.</td><td><a href=http://dx.doi.org/10.1152/ajplung.00302.2003>10.1152/ajplung.00302.2003</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Eichler W, Bechtel MJ, Klaus S, et al. Na/H<Superscript>+</Superscript> exchange inhibitor cariporide: effects on respiratory dysfunction after cardiopulmonary bypass.<Emphasis Type="Italic">Perfusion.</Emphasis>. 2004;19:33&#8211;40.</td><td><a href=http://dx.doi.org/10.1191/0267659104pf712oa>10.1191/0267659104pf712oa</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Larsson CI. The use of an &#8220;internal standard&#8221; for control of the recovery in microdialysis.<Emphasis Type="Italic">Life Sci.</Emphasis> 1991;49:PL73-PL78.</td><td><a href=http://dx.doi.org/10.1016/0024-3205(91)90082-M>10.1016/0024-3205(91)90082-M</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>De La Pena A, Dalla Costa T, Talton JD, et al. Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in rats.<Emphasis Type="Italic">Pharm Res.</Emphasis> 2001;18:1310&#8211;1314.</td><td><a href=http://dx.doi.org/10.1023/A:1013042128791>10.1023/A:1013042128791</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Eisenberg EJ, Conzentino P, Eickhoff WM, Cundy KC. Pharmacokinetic measurement of drugs in lung epithelial lining fluid by microdialysis: aminoglycoside antibiotics in rat bronchi.<Emphasis Type="Italic">J Pharmacol Toxicol Methods</Emphasis>. 1993;29:93&#8211;98.</td><td><a href=http://dx.doi.org/10.1016/1056-8719(93)90056-K>10.1016/1056-8719(93)90056-K</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>DeGuchi Y, Terasaki T, Yamada H, Tsuji A. An application of microdialysis to drug tissue distribution study: in vivo evidence for free-ligand hypothesis and tissue binding of beta-lactam antibiotics in interstitial fluids.<Emphasis Type="Italic">J Pharmacobiodyn.</Emphasis> 1992;15:79&#8211;89.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1248/bpb1978.15.79>10.1248/bpb1978.15.79</a></td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_2, Author_FamilyName_1, VolumeID, FirstPage</td><td>CrossRef</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European, Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee,.<Emphasis Type="Italic">JAMA</Emphasis>. 1995;274:639&#8211;644.</td><td><a href=http://dx.doi.org/10.1001/jama.274.8.639>10.1001/jama.274.8.639</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Bartlett JG Mundy LM. Community-acquired pneumonia.<Emphasis Type="Italic">N Engl J Med.</Emphasis> 1995;333:1618&#8211;1624.</td><td><a href=http://dx.doi.org/10.1056/NEJM199512143332408>10.1056/NEJM199512143332408</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Zeitlinger MA, Dehghanyar P, Mayer BX, et al. Relevance of soft-tissue penetration by levofloxacin for target site bacteria killing in patients with sepsis.<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 2003;47:3548&#8211;3553.</td><td><a href=http://dx.doi.org/10.1128/AAC.47.11.3548-3553.2003>10.1128/AAC.47.11.3548-3553.2003</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock.<Emphasis Type="Italic">Crit Care Med.</Emphasis> 2001;29:385&#8211;391.</td><td><a href=http://dx.doi.org/10.1097/00003246-200102000-00030>10.1097/00003246-200102000-00030</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Lambert HP. Clinical significance of tissue penetration of antibiotics in the respiratory tract.<Emphasis Type="Italic">Scand J Infect Dis Suppl.</Emphasis> 1978;14:262&#8211;266.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.<Emphasis Type="Italic">Clin Infect Dis</Emphasis>. 1998;26:1&#8211;12.</td><td><a href=http://dx.doi.org/10.1086/516284>10.1086/516284</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Drusano GL, Craig WA. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections.<Emphasis Type="Italic">J Chemother.</Emphasis> 1997;9:38&#8211;44.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Schentag JJ. Correlation of pharmacokinetic parameters to efficacy of antibiotics: relationships between serum concentrations MIC values, and bacterial eradication in patients with gram-negative pneumonia.<Emphasis Type="Italic">Scand J Infect Dis Suppl.</Emphasis> 1990;74:218&#8211;234.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR27</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>EMEA</span>. <span style='background:#FFD9B3'>Points to consider on pharmacokinetics and pharmacodynamics in the development of antibacteiral medicinal products</span>. Available at: <span style='background:#FF3300'>http://www.emea.en.int/pdfs/human/ewp/265599en.pdf</span>. Accessed October 11, <span style='background:#66FF66'>2005</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR28</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>FDA. Guidance for Industry</span>. <span style='background:#FFD9B3'>Developing antimicrobial drugs&#8212;general considerations for clinical trials</span>. Available at: <span style='background:#FF3300'>http://www.fda.gov/cder/guidance/2580dft.pdf</span>. Accessed October 11, <span style='background:#66FF66'>2005</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Bergogne-Berezin E. New concepts in the pulmonary disposition of antibiotics.<Emphasis Type="Italic">Pulm Pharmacol.</Emphasis> 1995;8:65&#8211;81.</td><td><a href=http://dx.doi.org/10.1006/pulp.1995.1009>10.1006/pulp.1995.1009</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Gail DB, Lenfant CJ. Cells of the lung: biology and clinical implications.<Emphasis Type="Italic">Am Rev Respir Dis.</Emphasis> 1983;127:366&#8211;387.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Marlin GE, Burgess KR, burgoyne J, Funnell GR, Guinness MD. Penetration of piperacillin into bronchial mucosa and sputum.<Emphasis Type="Italic">Thorax</Emphasis>. 1981;36:774&#8211;780.</td><td><a href=http://dx.doi.org/10.1136/thx.36.10.774>10.1136/thx.36.10.774</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Klastersky J, Thys JP, Mombelli G. Comparative studies of intermittent and continuous administration of aminogly cosides in the treatment of bronchopulmonary infectiosn due to gram-negative bacteria.<Emphasis Type="Italic">Rev Infect Dis.</Emphasis> 1981;3:74&#8211;83.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Brun Y, Forey F, Gamondes JP, Tebib A, Brune J, Fleurette J. Levels of erythromycin in pulmonary tissue and bronchial mucus compared to those of amoxycillin.<Emphasis Type="Italic">J Antimicrob Chemother</Emphasis>. 1981;8:459&#8211;466.</td><td><a href=http://dx.doi.org/10.1093/jac/8.6.459>10.1093/jac/8.6.459</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Jehl F, Muller-Serieys C, de Larminat V, Monteil H, Bergogne-Berezin E. Penetration of piperacillin-tazobactam, into bronchial secretions after multiple doses to intensive care patients.<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 1994;38:2780&#8211;2784.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1128/AAC.38.12.2780>10.1128/AAC.38.12.2780</a></td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, VolumeID, Author_FamilyName_1, Author_FamilyName_2, Year</td><td>CrossRef</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Bergogne-Berezin E, Muller-Serieys C, Aubier M, Dombret MC. Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy.<Emphasis Type="Italic">Eur J Clin Pharmacol</Emphasis>. 1994;46:87&#8211;88. Erratum in. Eur J Clin Pharmacol. 1994;46;282.</td><td><a href=http://dx.doi.org/10.1007/BF00195922>10.1007/BF00195922</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Cole DR, Pung J. Penetration of cefazolin into pleural fluid.<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 1977;11:1033&#8211;1035.</td><td><a href=http://dx.doi.org/10.1128/AAC.11.6.1033>10.1128/AAC.11.6.1033</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, Year, Author_FamilyName_2, Author_FamilyName_1, ArticleTitle, FirstPage</td><td>CrossRef</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Byl B, Jacobs F, Roucloux I, de Franquen P, Cappello M, Thys JP. Penetration of meropenem in lung, bronchial mucosa, and pleural tissues.<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 1999; 43:681&#8211;682.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Reynolds HY. Use of bronchoalveolar lavage in humans&#8212;past necessity and future imperative.<Emphasis Type="Italic">Lung.</Emphasis>. 2000;178:271&#8211;293.</td><td><a href=http://dx.doi.org/10.1007/s004080000032>10.1007/s004080000032</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Valcke Y, Pauwels R, Van der Straeten M. The penetration of aminoglycosides into the alveolar lining fluid of rats. The effect of airway inflammation.<Emphasis Type="Italic">Am Rev Respir Dis</Emphasis>. 1990;142:1099&#8211;1103.</td><td><a href=http://dx.doi.org/10.1164/ajrccm/142.5.1099>10.1164/ajrccm/142.5.1099</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Author_FamilyName_2, Year, JournalTitle, VolumeID, FirstPage</td><td>CrossRef</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Panteix G, Harf R, Desnottes JF, et al. Accumulation of pefloxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage.<Emphasis Type="Italic">J Antimicrob Chemother.</Emphasis> 1994;33:979&#8211;985.</td><td><a href=http://dx.doi.org/10.1093/jac/33.5.979>10.1093/jac/33.5.979</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Allegranzi B, Cazzadori A, Di Perri G, et al Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluid.<Emphasis Type="Italic">J Antimicrob Chemother</Emphasis>. 2000;46:319&#8211;322.</td><td><a href=http://dx.doi.org/10.1093/jac/46.2.319>10.1093/jac/46.2.319</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Harf R, Panteix G, Desnottes JF, Diallo N, Leclercq M. Spiramycin uptake by alveolar macrophages.<Emphasis Type="Italic">J Antimicrob Chemother</Emphasis>. 1988;22:135&#8211;140.</td><td><a href=http://dx.doi.org/10.1093/jac/22.2.135>10.1093/jac/22.2.135</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Le Conte P, Potel G, Peltier P, et al. Lung distribution and pharmacokinetics of aerosolized tobramycin.<Emphasis Type="Italic">Am Rev. Respir Dis</Emphasis>. 1993;147:1279&#8211;1282.</td><td><a href=http://dx.doi.org/10.1164/ajrccm/147.5.1279>10.1164/ajrccm/147.5.1279</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, ArticleTitle, Author_FamilyName_1, Author_FamilyName_2, Year, VolumeID</td><td>CrossRef</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Wollmer P, Pride NB, Rhodes CG, et al. Measurement of pulmonary erythromycin concentration in patients with lobar pneumonia by means of positron tomography.<Emphasis Type="Italic">Lancet.</Emphasis> 1982;320:1361&#8211;1364.</td><td><a href=http://dx.doi.org/10.1016/S0140-6736(82)91269-7>10.1016/S0140-6736(82)91269-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Allegranzi B. Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluid.<Emphasis Type="Italic">J Antimicrob Chemother</Emphasis>. 2000;46:319&#8211;322.</td><td><a href=http://dx.doi.org/10.1093/jac/46.2.319>10.1093/jac/46.2.319</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Baldwin DR, Honeybourne D, Wise R. Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 1992;36:1176&#8211;1180.</td><td><a href=http://dx.doi.org/10.1128/AAC.36.6.1176>10.1128/AAC.36.6.1176</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, VolumeID, Author_FamilyName_1, Year, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Decre D, Bergogne-Berezin E. Pharmacokinetics of quinolones with special reference to the respiratory tree.<Emphasis Type="Italic">J Antimicrob Chemother</Emphasis>. 1993;31:331&#8211;343.</td><td><a href=http://dx.doi.org/10.1093/jac/31.3.331>10.1093/jac/31.3.331</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR48</td><td>BibArticle</td><td>Braude AC, Hornstein A, Klein M, Vas S, Rebuck AS. Pulmonary disposition of to bramycin.<Emphasis Type="Italic">Am Rev Respir Dis</Emphasis> 1983;127:563&#8211;565.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Kunin CM. Clinical significance of protein binding of the penicillins.<Emphasis Type="Italic">Ann N Y Acad Sci.</Emphasis> 1967;145:282&#8211;290.</td><td><a href=http://dx.doi.org/10.1111/j.1749-6632.1967.tb50225.x>10.1111/j.1749-6632.1967.tb50225.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR50</td><td>BibArticle</td><td>Tulkens PM. Intracellular pharmacokinetics and localization of antibiotics as predictors of their efficacy against intraphagocytic infections.<Emphasis Type="Italic">Scand J Infect Dis Suppl.</Emphasis> 1990;74:209&#8211;217.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR51</td><td>BibArticle</td><td>Boselli E Breilh D Cannesson M, et al. Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia.<Emphasis Type="Italic">Intensive Care Med.</Emphasis> 2004;30:976&#8211;979.</td><td><a href=http://dx.doi.org/10.1007/s00134-004-2222-8>10.1007/s00134-004-2222-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR52</td><td>BibArticle</td><td>Nix DE, Goodwin SD, Peloquin CA, Rotella DL, Schentag JJ. Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 1991;35:1953&#8211;1959.</td><td><a href=http://dx.doi.org/10.1128/AAC.35.10.1953>10.1128/AAC.35.10.1953</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, ArticleTitle, Year, Author_FamilyName_2, Author_FamilyName_1, VolumeID</td><td>CrossRef</td></tr><tr><td>CR53</td><td>BibArticle</td><td>Zeitlinger M, Graninger W, Joukhadar C. Pharmacokinetics of the macrolides azithromycin, clarithromycin and roxithromycin in plasma and tissue&#8212;are there significant differences? In:<Emphasis Type="Italic">Wien Klin Wochenschr</Emphasis>. vol. 11&#8211;12a. 2004:18&#8211;24.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR54</td><td>BibArticle</td><td>Rodvold KA, Gotfried MH, Danziger LH, Servi RJ. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 1997;41:1399&#8211;1402.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR55</td><td>BibArticle</td><td>Poulin P, Theil FP. A priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery.<Emphasis Type="Italic">J Pharm Sci</Emphasis>. 2000;89:16&#8211;35.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1520-6017(200001)89:1&lt;16::AID-JPS3&gt;3.0.CO;2-E>10.1002/(SICI)1520-6017(200001)89:1&lt;16::AID-JPS3&gt;3.0.CO;2-E</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR56</td><td>BibArticle</td><td>Joukhadar C, Klein N, Mayer BX, et al. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis.<Emphasis Type="Italic">Crit Care Med.</Emphasis> 2002;30:1478&#8211;1482.</td><td><a href=http://dx.doi.org/10.1097/00003246-200207000-00013>10.1097/00003246-200207000-00013</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR57</td><td>BibArticle</td><td>Joukhadar, C, Stass H, Muller-Zellenberg U, et al. Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 2003;47:3099&#8211;3103.</td><td><a href=http://dx.doi.org/10.1128/AAC.47.10.3099-3103.2003>10.1128/AAC.47.10.3099-3103.2003</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR58</td><td>BibArticle</td><td>LeBel M. Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal.<Emphasis Type="Italic">Eur J Clin Microbiol Infect Dis</Emphasis> 1991;10:316&#8211;324.</td><td><a href=http://dx.doi.org/10.1007/BF01967005>10.1007/BF01967005</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR59</td><td>BibArticle</td><td>Mendelman PM, Smith AL, Levy J, Weber A, Ramsey B, Davis RL. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.<Emphasis Type="Italic">Am Rev Respir Dis.</Emphasis> 1985;132:761&#8211;765.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR60</td><td>BibArticle</td><td>Barza M, Cuchural G. General principles of antibiotic tissue penetration.<Emphasis Type="Italic">J Antimicrob Chemother</Emphasis>. 1985;15:59&#8211;75.</td><td><a href=http://dx.doi.org/10.1093/jac/15.suppl_A.59>10.1093/jac/15.suppl_A.59</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, VolumeID, Year, Author_FamilyName_2, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR61</td><td>BibArticle</td><td>Muller-Serieys C, Bancal C, Dombret MC, et al. Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients.<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 1992;36:2099&#8211;2103.</td><td><a href=http://dx.doi.org/10.1128/AAC.36.10.2099>10.1128/AAC.36.10.2099</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, VolumeID, Year, Author_FamilyName_2, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR62</td><td>BibArticle</td><td>Prokesch RC, Hand WL. Antibiotic entry into human polymorphonuclear leukocytes.<Emphasis Type="Italic">Antimicrob Agents Chemother</Emphasis>. 1982;21:373&#8211;380.</td><td><a href=http://dx.doi.org/10.1128/AAC.21.3.373>10.1128/AAC.21.3.373</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_2, Author_FamilyName_1, VolumeID, FirstPage, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR63</td><td>BibArticle</td><td>Forsgren A, Bellahsene A. Antibiotic accumulation in human polymorphonuclear leucocytes and lymphocytes.<Emphasis Type="Italic">Scand J Infect Dis Suppl</Emphasis>. 1985;44:16&#8211;23.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR64</td><td>BibArticle</td><td>Peck CC, Nichols AI, Baker J, Lenert LL, Ezra D. Clinical pharmacodynamics of theophylline.<Emphasis Type="Italic">J Allergy Clin Immunol.</Emphasis> 1985;76:292&#8211;297.</td><td><a href=http://dx.doi.org/10.1016/0091-6749(85)90644-X>10.1016/0091-6749(85)90644-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR65</td><td>BibArticle</td><td>Devarajan PV, Sule PN, Parmar DV. Comparative pharmacodynamic.-pharmacokinetic correlation of oral sustained-release theophylline formulation in adult asthmatics.<Emphasis Type="Italic">Drug Dev Ind Pharm</Emphasis>. 1999;25:529&#8211;534.</td><td><a href=http://dx.doi.org/10.1081/DDC-100102204>10.1081/DDC-100102204</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR66</td><td>BibArticle</td><td>Glynn-Barnhart A, Hill M, Szefler SJ. Sustained release theophylline preparations Practical recommendations for prescribing and therapeutic drug monitoring.<Emphasis Type="Italic">Drugs</Emphasis>. 1988;35:711&#8211;726.</td><td><a href=http://dx.doi.org/10.2165/00003495-198835060-00006>10.2165/00003495-198835060-00006</a></td><td>&nbsp;</td><td><b>ResearchGate-WebLink</b></td>
<td>Author_FamilyName_2, Year, Author_FamilyName_1, JournalTitle, VolumeID, FirstPage, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR67</td><td>BibArticle</td><td>Hook GE, Bend JR. Pulmonary metabolism of xenobiotics.<Emphasis Type="Italic">Life Sci.</Emphasis> 1976;18:279&#8211;290.</td><td><a href=http://dx.doi.org/10.1016/0024-3205(76)90056-4>10.1016/0024-3205(76)90056-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR68</td><td>BibArticle</td><td>Robertson CS, Gopinath SP, Uzura M, Valadka AB, Goodman JC. Metabolic changes in the brain during transient ischemia measured with microdialysis.<Emphasis Type="Italic">Neurol Res.</Emphasis> 1998;20:S91-S94.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR69</td><td>BibArticle</td><td>Frykholm P, Hillered L, Langstrom B, et al. Increase of interstitial glycerol reflects the degree of ischaemic brain damage: a PET and microdialysis study in a middle cerebral artery occulusion-reperfusion primate model.<Emphasis Type="Italic">J Neurol Neurosurg Psychiatry</Emphasis>. 2001;71:455&#8211;461.</td><td><a href=http://dx.doi.org/10.1136/jnnp.71.4.455>10.1136/jnnp.71.4.455</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR70</td><td>BibArticle</td><td>Parkin M, Hopwood S, Jones DA, et al. Dynamic changes in brain glucose and lactate in pericontusional areas of the human cerebral cortex, monitored with rapid sampling on-line microdialysis: relationship with depolarisation-like events.<Emphasis Type="Italic">J Cereb Blood Flow Metab</Emphasis>. 2005;25:402&#8211;413.</td><td><a href=http://dx.doi.org/10.1038/sj.jcbfm.9600051>10.1038/sj.jcbfm.9600051</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR71</td><td>BibArticle</td><td>Taggart DP, el-Fiky M, Carter R, Bowman A, Wheatley, DJ. Respiratory dysfunction after uncomplicated cardiopulmonary bypass.<Emphasis Type="Italic">Ann Thorac Surg</Emphasis>. 1993;56:1123&#8211;1128.</td><td><a href=http://dx.doi.org/10.1016/0003-4975(95)90029-2>10.1016/0003-4975(95)90029-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR72</td><td>BibArticle</td><td>Theroux P, Chaitman BR, Danchin N, et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators.<Emphasis Type="Italic">Circulation</Emphasis>. 2000;102:3032&#8211;3038.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR73</td><td>BibArticle</td><td>Afzelius BA. A human syndrome caused by immotile cilia.<Emphasis Type="Italic">Science</Emphasis>. 1976;193:317&#8211;319.</td><td><a href=http://dx.doi.org/10.1126/science.1084576>10.1126/science.1084576</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR74</td><td>BibArticle</td><td>Robinson M, Bye PT. Mucociliary clearance in cystic fibrosis.<Emphasis Type="Italic">Pediatr Pulmonol.</Emphasis> 2002;33:293&#8211;306.</td><td><a href=http://dx.doi.org/10.1002/ppul.10079>10.1002/ppul.10079</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>